Cure8 research brief
If hospital-treated infections raise later IBD risk—especially in people with certain immune-related genetic variants—this supports a multi-hit model of IBD and could eventually help identify higher-risk individuals after serious infections.
Researchers, clinicians caring for patients after serious infections, and adults with or at risk for IBD who are interested in genetic risk and disease triggers.
Researchers examined hospital-treated infections and subsequent incident IBD in a prospective cohort and performed gene–environment interaction analyses.
They report that multiple types and sites of infection were associated with higher IBD risk and that genetic risk variants in immune pathways modified that risk differently for Crohn's disease versus ulcerative colitis.
The team derived an Infection IBD Score based on 44 immune-related genes that they say stratifies post-infection risk; the abstract frames this as a potential risk‑stratification tool rather than a clinical test.
This classification and brief are based on the article abstract (structured content depth: abstract). The Infection IBD Score and gene–environment findings described in the abstract are exploratory and require full-text review and external validation before they could inform clinical decisions.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This research suggests genetic risk scores could help identify people with IBD who are more likely to have severe disease, which might eventually inform earlier monitoring or treatment decisions. It’s a step toward more...
A test that more accurately predicts which IBD patients with pre-cancerous bowel changes will develop cancer could help target surveillance and treatment to those at higher risk and reduce unnecessary procedures for...
This study links an HLA gene (DRB1) to shared T cell receptor patterns in both Crohn’s disease and ulcerative colitis, suggesting common immune targets across IBD subtypes. That could help researchers identify antigens...
